STAT3 and neoplasm: Further, Schneller et al. showed that constitutive active STAT3 reduces tumor formation of Ras-transformed, p19ARF-deficient hepatocytes, while increasing the tumor formation of Ras-transformed, p19ARF-proficient hepatocytes [122].